I saw similar articles (because I read everything I can about treatments for COVID), main thrust was they don't have enough of the stuff, so they need to begin producing more, seeing as we have runaway spreading and resurgence right now.
And if that's what anyone sold on, that just proves my point -- they clearly have no idea what that treatment means, and how or whether it impacts Rem-L's viability as a treatment for cases that don't respond to steroids.
I would really welcome downramping, so long as it is based upon factual information to show why the case for MSB's treatment isn't viable, eliminates the need for Rem-L treatment, etc. That is news I can use.
But this news is NOT it. Selling on this particular bit of (old) news = uninformed and easily scared.
-
- There are more pages in this discussion • 3,544 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.64 |
Change
-0.030(1.80%) |
Mkt cap ! $2.095B | |||
| Open | High | Low | Value | Volume |
| $1.67 | $1.67 | $1.62 | $23.20M | 14.15M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 217849 | $1.64 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.65 | 69336 | 2 |
View Market Depth
| Last trade - 16.10pm 20/06/2025 (20 minute delay) ? |
| MSB (ASX) Chart |